This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Gerlach JH et al . The sequence of the human genome Science 2001 291 : 1304 – 1351
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Gerlach JH et al . Initial sequencing and analysis of the human genome Nature 2001 409 : 860 – 921
Watson JD, Crick FHC . A structure for deoxyribose nucleic acid Nature 1953 171 : 737 – 738
Wodicka L, Dong H, Mittmann M, Ho MH, Lockhart DJ . Genome-wide expression monitoring in Saccharomyces cerevisiae Nature Biotechnol 1997 15 : 1359 – 1367
Prepared statement of J Craig Venter, president and chief scientific officer Celera Genomics, before the subcommittee on energy and environment US House of Representatives committee on Science, April 6th, 2000
Goodman LS et al (eds) . Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 9th edn McGraw-Hill: New York 1996
Bowcock AM, Kidd JR, Mountain JL, Hebert JM, Carotenuto L, Gerlach JH et al . Drift, admixture, and selection in human evolution: a study with DNA polymorphisms Proc Natl Acad Sci USA 1991 88 : 839 – 843
Gould SJ . Tempo and mode in the macroevolutionary reconstruction of Darwinism Proc Natl Acad Sci USA 1994 91 : 6764 – 6771
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grenet, O. Significance of the human genome sequence to drug discovery. Pharmacogenomics J 1, 11–12 (2001). https://doi.org/10.1038/sj.tpj.6500010
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500010
This article is cited by
-
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Nature Reviews Drug Discovery (2010)